Clinical Trial Update: Safety Study of Two Vaccine Strategies in Patients With Systemic Lupus Erythematosus [Phase 2, Phase 3]

View source ↗

Summary

Completed Phase 2/Phase 3 safety study evaluating two vaccine strategies in patients with systemic lupus erythematosus.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Systemic Lupus Erythematosus

Snippet

Sponsor: Assistance Publique - Hôpitaux de Paris | Conditions: Lupus Erythematosus, Systemic | Phase 2, Phase 3 | Status: COMPLETED